Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 1 43-1, 1998, Pages

  Oyekan, A O ^a   McGiff, J C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Clotrimazole; Cobalt chloride; Dibromododec 11 enoic acid; Endothelin 1; Indomethacin; Renal hemodynamics

Indexed keywords

CYTOCHROME P450; ENDOTHELIN 1; ICOSANOID;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DIURESIS; GLOMERULUS FILTRATION RATE; HORMONE ACTION; ICOSANOID METABOLISM; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY TUBULE; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031915821     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.1.r52     Document Type: Article

References (35)

1. Badr, K. F., J. J. Murray, M. D. Breyer, K. Takahashi. T. Inagami, and R. C. Harris. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J. Clin. Invest. 83: 336-342, 1989.
2. Carroll, M. A., M. Balazy, P. Margiotta, D.-D. Huang, J. R. Falck, and J. C. McGiff. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R863-R869, 1996.
3. Carroll, M. A., M. P. Garcia, J. R. Falck, and J. C. McGiff. Cyclooxygenase dependency of the renovascular actions of cytochrome P-450-derived arachidonate metabolites. J. Pharmacol. Exp. Ther. 260: 104-109, 1992.
4. Carroll, M. A., M. Schwartzman, M. Baba, M. J. S. Miller, and J. C. McGiff. Renal cytochrome P-450-related arachidonate metabolism in rabbit aortic coarctation. Am. J. Physiol. 255 (Renal Fluid Electrolyte Physiol. 24): F151-F157, 1988.
5. Escalante, B. E., D. Erlij, J. R. Falck, and J. C. McGiff. Effect of cytochrome P-450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 251: 799-802, 1991.
6. Ferrario, R. G., R. Foulkes, P. Salvati, and C. Patrono. Hemodynamic and tubular effects of endothelium and thromboxane in the isolated perfused kidney. Eur. J. Pharmacol. 17: 127-134, 1989.
7. Firth, J. D., and P. J Ratcliffe. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J. Clin. Invest. 90: 1023-1031, 1992.
8. Harris, P. J., J. Zuo, F. A. O. Mendelsohn, and S. L. Skinner. Hemodynamic and renal tubular effects of low doses of endothelin in anesthetized rats. J. Physiol. (Lond.) 433: 25-39, 1991.
9. Imig, J. D., A.-P. Zou, D. E. Stec, D. R. Harder, J. R. Falck, and R. J. Roman. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R217-R227, 1996.
10. Ishikawa, T., M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. Positive inotropic action of a novel vasoconstrictor peptide endothelin in guinea pig atria. Am. J. Physiol. 255 (Heart Circ. Physiol. 24): H970-H973, 1988.
11. Katoh, T., H. Chang, S. Uchida, T. Okuda, and K. Kurokawa. Direct effects of endothelin in the rat kidney. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F397-F402, 1990.
12. King, A. J., B. M. Brenner, and S. Anderson. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F1051-F1058, 1989.
13. Kon, V., and M. Awazu. Endothelins and cyclosporine nephrotoxicity. Ren. Fail. 14: 345-350, 1992.
14. Kon, V., T. Yoshioka, A. Fogo, and I. Ishikawa. Glomerular actions of endothelin in vivo. J. Clin. Invest. 83: 1762-1767, 1989.
15. Kramer, H. J., H. Meyer-Lehnert, H. Stelkens, A. Backer, and C. Wanning. Endothelin: an endogenous sodium transport inhibitor? (Abstract). Kidney Int. 35: 314, 1989.
16. Maines, M. D., and A. Kappas. Cobalt stimulation of heme degradation in the liver: dissociation of microsomal oxidation of heme from cytochrome P-450. J. Biol. Chem. 250: 4171-4177, 1975.
17. Makita, K., K. Takahashi, A. Karara, H. R. Jacobson, J. R. Falck, and J. H. Capdevilla. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P-450 epoxygenase induce hypertension in rats fed a high salt diet. J. Clin. Invest. 94: 2414-2420, 1994.
18. McGiff, J. C. Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 31: 339-369, 1991.
19. Miller, W. L., M. M. Redfield, and J. C. Burnett, Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 83: 317-320, 1989.
20. 2 in anesthetized dogs. Eur. J. Pharmacol. 170: 91-93, 1989.
21. Narumiya, S. Structures, properties and distributions of prostanoid receptors. Adv. Prostaglandin Thromboxane Leukot. Res. 23: 17-22, 1995.
22. Oishi, R., H. Nonoguchi, K. Tomita, and F. Marumo. Endothelin-1 inhibits arginine vasopressin stimulated osmotic water permeability in rat inner medullary collecting duct. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F951-F956, 1991.
23. Oyekan, A. O., M. Balazy, and J. C. McGiff. Renal oxygenases: differential contribution to vasoconstriction induced by endothelin-1 and angiotensin II. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R293-R300, 1997.
24. Payne, A. N., and B. J. R. Whittle. Potent cyclooxygenase-mediated bronchoconstrictor effects of endothelin in the guinea pig in vivo. Eur. J. Pharmacol. 158: 303-304, 1988.
25. Perico, N., R. P. Cornejo, A. Benigni, B. Malanchini, J. R. Ladny, and G. Remuzzi. Endothelin induces diuresis and natriuresis in the rat by acting on proximal tubular cells through a mechanism mediated by lipoxygenase products. J. Am. Soc. Nephrol. 2: 57-69, 1991.
26. Perico, N., J. Dadan, M. Gabanelli, and G. Remuzzi. Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin. J. Pharmacol. Exp. Ther. 252: 1213-1220, 1990.
27. Rubanyi, G. M., and M. A. Polokoff. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46: 328-415, 1994.
28. Sakairi, Y., H. R. Jacobson, T. D. Noland, J. H. Capdevilla, J. R. Falck, and M. D. Breyer. 5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F931-F939, 1995.
29. Schwartzman, M. L., N. G. Abraham, M. A. Carroll, R. D. Levere, and J. C. McGiff. Regulation of arachidonic acid metabolism by cytochrome P-450 in rabbit kidney. Biochem. J. 238: 283-290, 1986.
30. Simonson, M. S., and M. J. Dunn. Cellular signalling mechanisms by peptides of the endothelin gene family. FASEB J. 4: 2989-3000, 1990.
31. Stier, C. T., Jr., C. P. Quilley, and J. C. McGiff. Endothelin-3 effects on renal function and prostanoid release in the rat isolated kidney. J. Pharmacol. Exp. Ther. 262: 252-256, 1992.
32. Takizawa, H., M. Balazy, J. R. Zhu, J. R. Falck, and A. Nasjletti. 20-Hydroxyeicosatetraenoic acid mediates renal vasoconstriction in rats (Abstract). International Society of Hypertension, Glasgow, UK, June 23-27, 1996.
33. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
34. Zou, A.-P., J. D. Imig, M. Kaldunski, P. R. Ortiz de Montellano, Z.-H. Sui, and R. J. Roman. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F275-F282, 1994.
35. Zou, A.-P., J. D. Imig, P. R. Oritz de Montellano, Z.-H. Sui, J. R. Falck, and R. J. Roman. Effect of P-450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F934-F941, 1994.